Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7791214 | 0.82 | — | — | |
| SCHEMBL27825567 | 0.79 | TSHR (0.46) | MAPT | |
| SCHEMBL6422980 | 0.76 | — | — | |
| SCHEMBL4418767 | 0.75 | — | — | |
| SCHEMBL19372057 | 0.74 | TSHR (0.39) | MAPT | |
| SCHEMBL4419963 | 0.73 | MAPT (0.38) | ABCC4MAPT | |
| SCHEMBL10610970 | 0.73 | MAPT (0.38) | ABCC4MAPT | |
| SCHEMBL10609909 | 0.73 | MAPT (0.38) | ABCC4MAPT | |
| SCHEMBL10611257 | 0.73 | MAPT (0.38) | ABCC4MAPT | |
| SCHEMBL10611067 | 0.73 | MAPT (0.38) | ABCC4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0588875-B1 | MICROSPHERES USEFUL FOR THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THE SAME | BIOSEPRA SA (FR) | 1997-04-09 | — | — | EP | claimed |
| EP-0588875-A4 | — | — | 1994-08-03 | — | — | EP | claimed |
| EP-0588875-A1 | MICROSPHERES USEFUL FOR THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THE SAME. | SEPRACOR INC (US) | 1994-03-30 | — | — | EP | claimed |
| WO-1992021327-A1 | MICROSPHERES USEFUL FOR THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THE SAME | SEPRACOR, INC. (US) | 1992-12-10 | — | — | WO | claimed |
| EP-0099058-B1 | PROCESS FOR PRODUCING LOW-SHRINK POLYAMIDE MOULDED ARTICLES | BASF Aktiengesellschaft (DE) | 1986-04-23 | — | — | EP | claimed |
| US-11845823-B2 | Radiopaque monomers, polymers, microspheres, and methods related thereto | BIOSPHERE MEDICAL, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| EP-4245782-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL, INC. (US) | 2023-09-20 | — | — | EP | disclosed |
| EP-3660061-B1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL INC (US) | 2023-06-21 | — | — | EP | disclosed |
| US-20220016270-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2022-01-20 | — | — | US | disclosed |
| US-11116855-B2 | Radiopaque monomers, polymers, microspheres, and methods related thereto | BIOSPHERE MEDICAL, INC. (US) | 2021-09-14 | — | — | US | disclosed |
| EP-3245236-B1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL INC (US) | 2020-09-23 | — | — | EP | disclosed |
| EP-3660061-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | BIOSPHERE MEDICAL, INC. (US) | 2020-06-03 | — | — | EP | disclosed |
| EP-1059943-A1 | IMPLANTABLE PARTICLES FOR TISSUE BULKING AND THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE, URINARY INCONTINENCE, AND SKIN WRINKLES | Biosepra Medical Inc. (US) | 2000-12-20 | — | — | EP | disclosed |
| WO-1999044643-A1 | IMPLANTABLE PARTICLES FOR TISSUE BULKING AND THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE, URINARY INCONTINENCE, AND SKIN WRINKLES | BIOSEPRA MEDICAL INC. (US) | 1999-09-10 | — | — | WO | disclosed |
| US-5648100-A | Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (FR) | 1997-07-15 | — | — | US | disclosed |
| US-5635215-A | Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same | BIOSEPRA S.A. (FR) | 1997-06-03 | — | — | US | disclosed |
| EP-0588875-B1 | MICROSPHERES USEFUL FOR THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THE SAME | BIOSEPRA SA (FR) | 1997-04-09 | — | — | EP | disclosed |
| EP-0588875-A4 | — | — | 1994-08-03 | — | — | EP | disclosed |
| EP-0588875-A1 | MICROSPHERES USEFUL FOR THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THE SAME. | SEPRACOR INC (US) | 1994-03-30 | — | — | EP | disclosed |
| WO-1992021327-A1 | MICROSPHERES USEFUL FOR THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THE SAME | SEPRACOR, INC. (US) | 1992-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220016270-A1 | RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO | CD68, MVD, RAD54L | ABCC4 4534/4885MAPT 1802/4885 |
| US-11116855-B2 | Radiopaque monomers, polymers, microspheres, and methods related thereto | CD68, MVD, RAD54L | ABCC4 4534/4885MAPT 1802/4885 |
| US-11845823-B2 | Radiopaque monomers, polymers, microspheres, and methods related thereto | CD68, MVD, RAD54L | ABCC4 4534/4885MAPT 1802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.